查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1775447

全球乳房摄影影像市场：2025-2030 年预测

Global Breast Imaging Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计乳房摄影影像市场规模将从 2025 年的 50.75 亿美元成长至 2030 年的 73.94 亿美元，复合年增长率为 7.82%。

提高乳癌发生率和认知度

世界卫生组织 (WHO) 指出，乳癌仍然是全球女性最常见的癌症之一，已开发国家和开发中国家均受影响。乳癌存活率低的主要原因是早期发现计画不足以及缺乏定期筛检的意识，导致患者确诊时已是晚期。随着乳癌发生率的上升，女性越来越意识到及时筛检的重要性，透过早期发现可以显着降低患病风险。这些变化推动了对先进乳房摄影影像设备的需求，并刺激了市场扩张，因为医疗保健提供者优先考虑能够提高诊断准确性和患者预后的技术。

采用先进的影像诊断技术

市场受益于创新乳房摄影方式的采用，这些方式提高了诊断效率。分子乳房摄影(MBI)、造影乳房X光摄影(CEM)、正子乳房 X 光乳房X光摄影(PEM)、电电阻测试 (EIT) 和光学影像检查等技术正变得越来越普遍。 MBI 是一种核医学方法，涉及注射化学示踪剂和使用专门的相机来评估乳房异常，特别是对于乳房緻密或乳房乳房X光摄影异常的女性。 CEM 使用碘基显影剂来突出显示异常乳房组织，是 MRI 的一种经济有效的替代方案。 PEM 与 PET 类似，使用放射性糖来检测小簇癌细胞。 EIT 利用癌细胞和正常细胞之间的电导率差异，而光学成像则分析光透射以监测癌症生长。儘管存在 MBI 和 PEM 中的辐射暴露等挑战，但这些方法透过实现更精确的诊断促进了市场发展。

技术进步

乳房摄影成像技术的不断创新是主要驱动因素。先进的系统正在开发中，其检测和监测癌细胞扩散的能力得到了提升，从而提高了诊断准确性和工作流程效率。随着製造商推出多样化、高效能的影像解决方案，这些进步预计将在医疗保健领域得到更广泛的应用。由于医疗保健提供者努力满足对早期有效乳癌检测日益增长的需求，对能够提供更快、更准确结果的先进设备的关注预计将在预测期内推动市场成长。

市场挑战

儘管技术不断进步，但某些影像技术（例如MBI和PEM）仍涉及辐射暴露，限制了其在常规筛检中的应用。新兴方法（例如EIT和光学成像）需要进一步的临床检验和基础设施投资，这为其广泛应用带来了障碍。这些挑战凸显了持续研究的必要性，以平衡诊断效果与病人安全性和可近性。

区域展望

由于乳癌的高发病率和不断上升的死亡率，预计北美将在整个预测期内占据主导市场占有率，这推动了对先进诊断影像解决方案的投资和宣传宣传活动。在加强诊断设施和医疗保健基础设施的努力下，亚太地区预计将扩大市场占有率。这些区域趋势反映了不同的医疗保健重点和投资，从而塑造了市场的成长轨迹。

结论

受乳癌患者数量成长、早期检测意识增强以及创新影像技术推动，乳房摄影影像市场正呈现强劲成长势头。北美凭藉其高发病率和投资额度，占据市场领先地位；而亚太地区则有望透过改善诊断基础设施来实现成长。儘管存在辐射风险和实施障碍等挑战，但MBI、CEM、PEM、EIT、光学成像等领域的进步正在拓展市场机会。产业专家应注意到，技术创新和区域动态在塑造市场未来发展中发挥关键作用。

本报告的主要优点

  • 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要企业采取的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 适用范围广：对于新兴企业、科学研究机构、顾问公司、中小企业、大型企业都有利且划算。

它有什么用途？

产业与市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测包括国家在内的细分市场和地区分析
  • 公司概况（特别是财务状况和关键发展）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章乳房摄影影像市场（按技术）

  • 介绍
  • 乳房X光检查
  • 超音波
  • 磁振造影（MRI）
  • 核子造影
  • 其他的

第六章乳房摄影影像市场（依程序）

  • 介绍
  • 乳房X筛检
  • 诊断性乳房X光检查
  • 乳房断层合成
  • 乳腺超音波
  • 乳房MRI
  • 其他的

第七章乳房摄影诊断市场（按最终用户）

  • 介绍
  • 医院
  • 诊断中心
  • 研究部门

第八章乳房摄影诊断市场（按区域）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • GE Healthcare
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • Dilon Technologies, Inc.

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613457

The Global Breast Imaging Market is expected to grow from USD 5.075 billion in 2025 to USD 7.394 billion in 2030, at a CAGR of 7.82%.

Increasing Breast Cancer Incidence and Awareness

Breast cancer remains one of the most prevalent cancers affecting women globally, as noted by the World Health Organization, with significant impact in both developed and developing nations. Low survival rates are primarily due to inadequate early detection programs and limited awareness of routine screenings, leading to late-stage diagnoses. The growing incidence of breast cancer is driving heightened awareness among women about the importance of timely checkups, which significantly reduce risks through early detection. This shift is increasing demand for advanced breast imaging equipment, fueling market expansion as healthcare providers prioritize technologies that enhance diagnostic accuracy and patient outcomes.

Adoption of Advanced Imaging Techniques

The market is benefiting from the adoption of innovative breast imaging methods that improve diagnostic efficiency. Techniques such as molecular breast imaging (MBI), contrast-enhanced mammography (CEM), positron emission mammography (PEM), electrical impedance testing (EIT), and optical imaging tests are gaining traction. MBI, a nuclear medicine approach, involves injecting a chemical tracer and using a specialized camera to evaluate breast abnormalities, particularly for women with dense breasts or abnormal mammograms. CEM uses iodine-based contrast dye to highlight abnormal breast tissue, offering a cost-effective alternative to MRI. PEM, akin to PET scans, employs radioactive sugar to detect small cancer cell clusters. EIT leverages differences in electrical conductivity between cancerous and normal cells, while optical imaging analyzes light transmission to monitor cancer growth. These methods, despite challenges like radiation exposure in MBI and PEM, are driving the development of enhanced imaging equipment, contributing to market growth by enabling more precise diagnostics.

Technological Advancements

Continuous innovation in breast imaging technologies is a key growth driver. Advanced systems with improved capabilities for detecting and monitoring cancer cell spread are being developed, enhancing diagnostic precision and workflow efficiency. These advancements are expected to increase adoption across healthcare settings, as manufacturers introduce diverse, high-performance imaging solutions. The focus on sophisticated equipment that delivers faster, more accurate results is anticipated to propel market growth over the forecast period, as providers seek to meet rising demand for early and effective breast cancer detection.

Market Challenges

Despite technological progress, certain imaging techniques, such as MBI and PEM, involve radiation exposure, limiting their use in routine screening. Emerging methods like EIT and optical imaging require further clinical validation and infrastructure investment, posing barriers to widespread adoption. These challenges highlight the need for ongoing research to balance diagnostic efficacy with patient safety and accessibility.

Regional Outlook

North America is expected to maintain a dominant market share through the forecast period, driven by the high prevalence of breast cancer and increasing mortality rates, which are prompting greater investment in advanced imaging solutions and awareness campaigns. The Asia Pacific region is poised to expand its market share, supported by initiatives to enhance diagnostic facilities and healthcare infrastructure. These regional trends reflect varying healthcare priorities and investments, shaping the market's growth trajectory.

Conclusion

The breast imaging market is on a strong growth path, driven by rising breast cancer cases, growing awareness of early detection, and innovative imaging technologies. North America leads due to high disease prevalence and investment, while Asia Pacific is set to grow through improved diagnostic infrastructure. Despite challenges like radiation risks and adoption barriers, advancements in MBI, CEM, PEM, EIT, and optical imaging are expanding market opportunities. Industry experts should note the critical role of technological innovation and regional dynamics in shaping the market's future.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Technology

  • Mammography
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging
  • Others

By Procedure

  • Screening Mammography
  • Diagnostic Mammography
  • Breast Tomosynthesis
  • Breast Ultrasound
  • Breast MRI
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BREAST IMAGING MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Mammography
  • 5.3. Ultrasound
  • 5.4. Magnetic Resonance Imaging (MRI)
  • 5.5. Nuclear Imaging
  • 5.6. Others

6. BREAST IMAGING MARKET BY PROCEDURE

  • 6.1. Introduction
  • 6.2. Screening Mammography
  • 6.3. Diagnostic Mammography
  • 6.4. Breast Tomosynthesis
  • 6.5. Breast Ultrasound
  • 6.6. Breast MRI
  • 6.7. Others

7. BREAST IMAGING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Diagnostic Centers
  • 7.4. Research Laboratories

8. BREAST IMAGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Australia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. GE Healthcare
  • 10.2. Hologic, Inc.
  • 10.3. Siemens Healthineers AG
  • 10.4. Koninklijke Philips N.V.
  • 10.5. Fujifilm Holdings Corporation
  • 10.6. Canon Medical Systems Corporation
  • 10.7. Dilon Technologies, Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations